Name: Ferric Chloride-induced Murine Thrombosis Models (Video) | JoVE Journal
Uploaded: 2016-09-05T13:00:00.000+00:00
Duration: 10 min 37 s
Description: Learn ferric chloride-induced thrombosis in mouse carotid and mesenteric artery models using intravital microscopy. This sensitive technique enables real-time visualization of platelet aggregation and drug evaluation.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health under award numbers R01 HL121212 (PI: Sen Gupta), R01 HL129179 (PI: Sen Gupta, Co-I: Li) and R01 HL098217 (PI: Nieman). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

All procedures and manipulations of animals have been approved by Institutional Animal Care and Use Committees (IACUC) of The Cleveland Clinic in accordance with the United States Public Health Service Policy on the Humane Care and Use of Animals, and the NIH Guide for the Care and Use of Laboratory Animals.
1. Preparations:
<ol>
	<li>Fluorescent Dye for Labeling Platelets
	<ol>
		<li>Prepare rhodamine 6G solution, 0.5 mg/ml, in saline and sterilize the solution with 0.22 &#181;m filter.</li>
	</ol>
	</li>
	<li>FeCl3 Solution
	<ol>
		<li>Make a fresh stock solution of 30% FeCl3 (Anhydrous, equals 1.85 M) in pure water, and filter with 0.45 &#181;m filter. Prepare 5 ml fresh FeCl3 solution at the desired concentration [e.g., 2.5% (0.154 M), 5% (0.308 M), 7.5% (0.463 M), 10% (0.617 M) and 12.5% (0.771 M)] by diluting the 30% FeCl3 solution with water in a 6 cm tissue culture dish and keep the lid closed. 
		NOTE: Using the culture dish makes it easier to pick up the filter paper saturated with FeCl3 solution than to pick it up from a narrow container, such as a 1.5 ml microcentrifuge tube.&#160;&#160;FeCl3 is extremely hazardous and that precautions, such as wearing gloves and lab coat etc., Personal Protective Equipment, should always be taken.</li>
	</ol>
	</li>
	<li>Filter Papers
	<ol>
		<li>Cut the filter paper to 1 mm x 2 mm size. Soak enough pieces of the cut filter paper in the FeCl3 solution in the same dish.</li>
	</ol>
	</li>
	<li>Papaverine Hydrochloride Solution
	<ol>
		<li>Prepare papaverine hydrochloride solution (25 mg/ml) in water and sterilize the solution with 0.22 &#181;m filter.</li>
	</ol>
	</li>
	<li>Agarose Gel
	<ol>
		<li>Prepare 2% agarose gel in PBS or saline in 6-well tissue culture plate, ~ 1 cm thickness, and cut it to half-circle with ~ 3 cm diameter.</li>
	</ol>
	</li>
</ol>
2. FeCl3 Induced Carotid Arterial Injury Thrombosis Model
<ol>
	<li>Surgical Procedures for the Thrombosis Model
	<ol>
		<li>Use 8 - 12 weeks old C57Bl6 mice (or other strains as necessary). Anesthetize mice with the mixture of ketamine (100 mg/kg)/xylazine (10 mg/kg) via intraperitoneal injection. Confirm the depth of the anesthesia by toe pinching. 
		NOTE: This amount of ketamine/xylazine is sufficient to keep the animal in stable anesthesia and no pain (response to toe pinching) for at least 1 hr.</li>
		<li>Remove fur on the neck and upper chest with a small animal electric clipper. Depilatory cream is not necessary. Apply neutral petroleum eye&#160;ointment on the eyes to prevent dryness during anesthesia.</li>
		<li>Secure the mouse in the supine position on the lid of 15 cm tissue culture plate. Use one long tape (~ 10 cm) to secure hind limbs and lower body, and two pieces of small tape (2 cm x 0.5 cm) to secure forelegs. Use a 4-0 suture to wrap around the incisors, tape the two ends of the suture to the lid to keep mouse neck straight (Figure 2).</li>
		<li>Place plate with mouse head toward the operator under a surgical light source.</li>
		<li>Sterilize the surgical site with alcohol pad. Use the Micro-Adson Forceps to hold the skin and use a surgical scissors to make a small incision (2 - 3 mm).</li>
		<li>Hold the skin of the incision with the forceps and insert surgical scissors with jaws closed into the incision. Push the scissors subcutaneously toward the manubrium or chin, and then open the scissors to free the skin from the subcutaneous layer.</li>
		<li>Cut the skin with the surgical scissors to make a midline incision from the manubrium to the level of hyoid bone (Figure 3A and 3B). Bluntly dissect the thin fascia (dotted line, in Figure 3B) between the submaxillary glands with a fine hemostat and a Graefe forceps (Figure 3B and 3C; blue arrows). 
		NOTE: The manubrium (black arrow in Figure 3C) and the trachea (T in Figure 3C) will be seen after this step.</li>
		<li>Hold the soft tissue and the skin seen at the right of the manubrium with the Graefe forceps, insert the hemostat under the fascia toward the 2 o&#39;clock position (yellow dotted line in Figure 3C), open the jaws of the hemostat to free the jugular vein from surrounding tissue.</li>
		<li>Cut the fascia, soft tissue and skin toward the 2 o&#39;clock position (Figure 3C) with the surgical scissors to expose the right jugular vein (Figure 3D, arrow).</li>
		<li>Draw about 200 - 300 &#181;l rhodamine 6G solution using a 1 ml syringe with 22 G needle, and then change it to 30 G needle. 
		NOTE: This protects the 30 G needle from damage of its fine tip.&#160; Directly drawing the rhodamine 6G solution with the 30 G needle will not damage the tip; however touching the container wall accidentally will cause damage, which may make injection difficult.</li>
		<li>Flush the 30 G needle by slowly pushing out the rhodamine 6G solution, make sure no air bubbles remain in the syringe or the needle. Keep 100 &#181;l rhodamine 6G solution for injection.</li>
		<li>Bend 2 - 3 mm tip of the needle to a 90&#176; angle with the needle holder, which will prevent inserting the needle too deep to the jugular vein and makes the injection more easily controlled (Figure 3D).</li>
		<li>Inject the rhodamine 6G solution into the right jugular vein to label platelets. To stabilize the syringe and keep the needle in position, hold the syringe with one hand and the needle with the Graefe forceps with another hand during the injection.After injection, clamp the injection site with the Graefe forceps to avoid bleeding.</li>
		<li>Open the jaws of the hemostat and insert it under the Graefe forceps to clamp the vessel wall of the injection site, and then ligate the injection site with a 6-0 suture. 
		NOTE: As an alternative of step 2.1.15, applying pressure to the injection site with a finger for 2 min will stop the bleeding; however, this method has a risk of causing further bleeding if the clot at the injection site is removed accidently.</li>
		<li>Bluntly dissect the soft tissue and fascia around the left submaxillary gland with the hemostat and the Graefe forceps and pull the gland toward the 7 o&#39;clock position (Figure 3E) to expose the left sternocleidomastoid muscle (blue arrow in Figure 3E).</li>
		<li>Bluntly dissect the fascia (Figure 3E, dotted line) between the left sternocleidomastoid muscle and the omohyoid muscle or the sternohyoid muscle (Figure 3E, green arrow) located to the left site of the trachea with the hemostat.</li>
		<li>Pass a needle with 6-0 silk suture (about 15 cm long) under the middle of the sternocleidomastoid muscle (blue arrow in Figure 3E), put the two ends of the suture together and pull the suture laterally toward the 10 o&#39;clock position. 
		NOTE: This procedure should be performed carefully to avoid injury of the left jugular vein, which is located outside of the sternocleidomastoid muscle.</li>
		<li>Bluntly separate the thin sternohyoid muscle and/or omohyoid muscle to expose the carotid artery (CA) (Figure 3F arrow) after pulling away the sternocleidomastoid muscle. Cut the sternohyoid muscle and/or omohyoid muscle as necessary. Use the hemostat to separate the soft tissue from CA without touching the CA. 
		NOTE: CA is accompanied by the vagus nerve, the white structure seen in Figure 3G (green arrow), and in most cases it is under the thin sternohyoid muscle and/or omohyoid muscle (between the yellow dotted lines in Figure 3F).</li>
		<li>Use a fine tip forceps to pick up the lateral fascia around the CA while avoiding the vagus nerve and CA. Use another fine tip forceps to punch a hole on the fascia between the CA and vagus nerve.</li>
		<li>Pass the hook through the hole and gently lift the CA, and then place the fine tip forceps under the CA. Move the hook and forceps in opposite directions along the CA to strip adventitial soft tissue. Free at least ~ 5 mm length of CA (Figure 3H, blue arrow) from surrounding tissue.</li>
		<li>To block background fluorescence, press the end of a black plastic coffee stirrer to flat, crosscut the coffee stirrer into a 3 mm piece, and then cut longitudinally along the fold edges to get two pieces of &#34;U&#34; shape plastic (Figure 3H, green arrow).</li>
		<li>Rinse one piece of this &#34;U&#34; shape plastic with saline and hold it with forceps and place it under the CA while gently lifting the CA with the hook (Figure 3H, green arrow). Immediately apply 2-3 drops of saline to avoid drying the CA.</li>
	</ol>
	</li>
	<li>Real time Recording Video
	<ol>
		<li>Transfer the mouse and plate lid together to the microscope stage and place in an appropriate position under the 10X water lens. Fill the space between the 10X lens and the CA with saline.</li>
		<li>Start the digital video recording software application, and launch a new file and name it accordingly. Record normal vessel images and write down the frame number when the video recording is stopped. 
		NOTE: Reference the video recording software in the computer for recording. We use digital video recording software and the following descriptions are based on this application.&#160; 
		NOTE: Since mechanical trauma can injure the endothelium and lead to thrombus formation20, it is necessary to confirm that there is no surgical injury to the vessel wall prior to the FeCl3 injury. It is also necessary to confirm that there is no remaining tissue around the CA, which may form a barrier and attenuate the effect of FeCl3-induced injury. Write down the frame number of the records will make it easy to analyze the videos according elapsed times later.</li>
		<li>Move the mouse with plate lid out of the 10X lens. Fold a corner of a paper towel to make a thin and fine tip and use it to carefully blot the saline around the CA (avoid touching CA) as well as in other places in the surgical field. This is important to avoid dilution of the FeCl3 solution used.</li>
		<li>Use a fine tip forceps and pick up a piece of filter paper saturated with FeCl3 solution and place it directly on the CA and keep it on site for 1 min. 
		NOTE: To aid visualization of the bloodstream and harvest accurate data, place the filter paper close to the distal end of the exposed CA (Figure 3I) and leave a short segment at the proximal site (green arrow in Figure 3I) for observing blood flow at late phase (see below).</li>
		<li>Remove the filter paper (this time point is defined as the start of &#8220;after injury&#8221;) and rinse the CA with saline (at least 2 ml). &#160;</li>
		<li>Put the mouse with plate lid back to the 10X lens; observe the vessel and start to record video images. Write down the video frame number at the end of the first minute of recording. 
		NOTE: Thrombus formation is identified by accumulation of the fluorescent platelets, which is observed in real-time video images on computer screen or under microscope. Record video images immediately after putting the mouse back under the microscope. Keep recording to the end of the first minute after removing the filter paper. Observe the entire vessel from the distal to the proximal sites to obtain information about the injury, and then focus on the area of interest (usually is the center of the injured area) for further imaging.</li>
		<li>Record video images for 10 sec every minute for the first 10 min (e.g., 2:55 to 3:05) and then 10 sec every other minute until the end of the experiment. Write down the frame numbers when each recording is stopped. 
		NOTE: The end points of the model are: 1) when blood flow has ceased for &#62;&#160; 30 sec; or 2) if occlusion is not seen in 30 min after injury. In this case, use 30 min for statistical analysis. Set Exposure Time of the video record as 10 msec at the beginning, so it will be easy to observe the blood flow over the thrombi. When the thrombi become large and the fluorescence saturates the camera&#8217;s sensor, it becomes difficult to identify the blood flow over thrombi. To solve this issue, move the imaging center to the proximal uninjured site (Figure 3I, green arrow) where blood flow can still be clearly observed. We also increase the Expose Time to 15 or 20 msec when focusing on the proximal un-injured site, so the blood flow can be observed more clearly. When blood flow will cease, numerous larger cells (leukocytes) start to roll on the vessel wall at the proximal site of the thrombus. Flow usually stops within 2 - 3 min after the appearance of the large cells. Write down the Expose Time on the recording sheet if it is changed. It usually takes about 30 min from the anesthesia to the end of the experiment, if the normal wild type C57Bl6 mice were used. 
		CAUTION NOTE: Don&#39;t use the white aggregated platelet clot as the sign of the blood flow cessation, which will not give an accurate data and it is affected by the exposure time. The white clot covered the vessel lumen does not mean blood flow ceased (see the representative video 1).</li>
		<li>At the end of experiment, euthanize the mice using overdose ketamine/xylazine (200/20 mg/Kg), followed by cervical dislocation after confirming no breath and heartbeat.</li>
	</ol>
	</li>
</ol>
3. FeCl3 Induced Mesenteric Artery/Vein Thrombosis Model
<ol>
	<li>Anesthetize 8 &#8722; 12 week old C57Bl6 mice as mentioned in section 2.1.1. Apply vet ointment on the eyes to prevent dryness during anesthesia.</li>
	<li>Inject Papaverine solution (total 0.4 mg/mouse) intraperitoneally to inhibit gut peristalsis.</li>
	<li>Remove fur on the neck and abdomen with an animal electric clipper. Depilatory cream is not necessary.</li>
	<li>Secure the mouse in the supine position on the lid of 15 cm tissue culture plate. Use four pieces of small tape (2 cm x 0.5 cm) to secure all legs. Use a 4 -0 suture to wrap around the incisors, tape the two ends of the suture to the lid to keep the neck straight (Figure 2).</li>
	<li>Follow procedures 2.1.4 - 2.1.15 to expose the jugular vein for injection of rhodamine 6G to label platelets.</li>
	<li>Perform a midline incision through the skin from xiphoid to lower abdomen using the surgical scissors (Figure 4A). Pick up the middle peritoneum (also called linea alba, Figure 4A, arrow) with Graefe forceps, which is clear and has no blood vessels, lift about 2 - 3 mm high, confirm no bowel under the cutting line, and cut the peritoneum open longitudinally with the fine scissors (Figure 4B).</li>
	<li>Re-secure the mice to right lateral position. Place the half-circle agarose gel close to the abdomen, and gently exteriorize the intestines and spread it on the top of the gel with the Graefe forceps (Figure 4C). Use the second branches for the thrombosis experiment (Figure 4C, arrow). 
	NOTE: Use the hemostat or Micro-Adson forceps to help to exteriorize the intestines. Avoid hurting the bowel and the vessel.</li>
	<li>Place 5 - 6 drops saline to keep the moisture of the bowel and vessel. Transfer the mouse with the plate lid together to the microscope stage and place in appropriate position under the 10X dry lens. 
	NOTE: Use a dry lens because the jejunoileal membrane cannot hold saline solution. Make sure to drop saline solution on the exposed tissues to keep them moist.</li>
	<li>Blot the saline around the mesenteric artery and vein before treatment.</li>
	<li>Use a fine tip forceps to pick up a piece of filter paper saturated with 12.5% FeCl3 solution and place it directly on the mesenteric artery and vein for 1 min (Figure 4D).&#160; Remove the filter paper (this time point is defined as the start of &#8220;after injury&#8221;) and rinse the injured mesenteric artery and vein with saline (at least 2 ml). &#160;</li>
	<li>Put the mouse with plate lid back under the 10X dry lens; observe the vessels and start to record video images as mentioned in 2.2). 
	NOTE: The end points of this experiment are: 1) when blood flow has ceased for &#62; 30 sec; or 2) if occlusion is not seen in 30 min after injury, and in this case use 30 min for statistical analysis.</li>
	<li>At the end of experiment, euthanize the mice using overdose ketamine/xylazine (200/20 mg/Kg), followed by cervical dislocation after no breath and heart beating are confirmed.</li>
</ol>

<ol><li>Sachs, U. J., Nieswandt, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vivo+thrombus+formation+in+murine+models%5BTitle%5D)+AND+%22Circ+Res%22%5BJournal%5D)">In vivo thrombus formation in murine models.</a> Circ Res. 100, 979-991 (2007).</li>
<li>Libby, P., Lichtman, A. H., Hansson, G. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Immune+effector+mechanisms+implicated+in+atherosclerosis%3A+from+mice+to+humans%5BTitle%5D)+AND+%22Immunity%22%5BJournal%5D)">Immune effector mechanisms implicated in atherosclerosis: from mice to humans.</a> Immunity. 38, 1092-1104 (2013).</li>
<li>Ruggeri, Z. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Platelet+adhesion+under+flow%5BTitle%5D)+AND+%22Microcirculation%22%5BJournal%5D)">Platelet adhesion under flow.</a> Microcirculation. 16, 58-83 (2009).</li>
<li>Watson, S. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Platelet+activation+by+extracellular+matrix+proteins+in+haemostasis+and+thrombosis%5BTitle%5D)+AND+%22Curr+Pharm+Des%22%5BJournal%5D)">Platelet activation by extracellular matrix proteins in haemostasis and thrombosis.</a> Curr Pharm Des. 15, 1358-1372 (2009).</li>
<li>Furie, B., Furie, B. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Thrombus+formation+in+vivo%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">Thrombus formation in vivo.</a> J Clin Invest. 115, 3355-3362 (2005).</li>
<li>Li, W., McIntyre, T. M., Silverstein, R. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ferric+chloride-induced+murine+carotid+arterial+injury%3A+A+model+of+redox+pathology%5BTitle%5D)+AND+%22Redox+Biol%22%5BJournal%5D)">Ferric chloride-induced murine carotid arterial injury: A model of redox pathology.</a> Redox Biol. 1, 50-55 (2013).</li>
<li>Ghosh, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Platelet+CD36+mediates+interactions+with+endothelial+cell-derived+microparticles+and+contributes+to+thrombosis+in+mice%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice.</a> J Clin Invest. 118, 1934-1943 (2008).</li>
<li>Chen, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vav+guanine+nucleotide+exchange+factors+link+hyperlipidemia+and+a+prothrombotic+state%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state.</a> Blood. , (2011).</li>
<li>Li, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((CD36+participates+in+a+signaling+pathway+that+regulates+ROS+formation+in+murine+VSMCs%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.</a> J Clin Invest. 120, 3996-4006 (2010).</li>
<li>Chen, K., Febbraio, M., Li, W., Silverstein, R. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+specific+CD36-dependent+signaling+pathway+is+required+for+platelet+activation+by+oxidized+low-density+lipoprotein%5BTitle%5D)+AND+%22Circ+Res%22%5BJournal%5D)">A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.</a> Circ Res. 102, 1512-1519 (2008).</li>
<li>Kurz, K. D., Main, B. W., Sandusky, G. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rat+model+of+arterial+thrombosis+induced+by+ferric+chloride%5BTitle%5D)+AND+%22Thromb+Res%22%5BJournal%5D)">Rat model of arterial thrombosis induced by ferric chloride.</a> Thromb Res. 60, 269-280 (1990).</li>
<li>Konstantinides, S., Schafer, K., Thinnes, T., Loskutoff, D. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Plasminogen+activator+inhibitor-1+and+its+cofactor+vitronectin+stabilize+arterial+thrombi+after+vascular+injury+in+mice%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.</a> Circulation. 103, 576-583 (2001).</li>
<li>Leadley, R. J. Jr, et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pharmacodynamic+activity+and+antithrombotic+efficacy+of+RPR120844%2C+a+novel+inhibitor+of+coagulation+factor+Xa%5BTitle%5D)+AND+%22J+Cardiovasc+Pharmacol%22%5BJournal%5D)">Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novel inhibitor of coagulation factor Xa.</a> J Cardiovasc Pharmacol. 34, 791-799 (1999).</li>
<li>Marsh Lyle, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessment+of+thrombin+inhibitor+efficacy+in+a+novel+rabbit+model+of+simultaneous+arterial+and+venous+thrombosis%5BTitle%5D)+AND+%22Thromb+Haemost%22%5BJournal%5D)">Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis.</a> Thromb Haemost. 79, 656-662 (1998).</li>
<li>Farrehi, P. M., Ozaki, C. K., Carmeliet, P., Fay, W. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Regulation+of+arterial+thrombolysis+by+plasminogen+activator+inhibitor-1+in+mice%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice.</a> Circulation. 97, 1002-1008 (1998).</li>
<li>Robertson, J. O., Li, W., Silverstein, R. L., Topol, E. J., Smith, J. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Deficiency+of+LRP8+in+mice+is+associated+with+altered+platelet+function+and+prolonged+time+for+in+vivo+thrombosis%5BTitle%5D)+AND+%22Thromb+Res%22%5BJournal%5D)">Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis.</a> Thromb Res. 123, 644-652 (2009).</li>
<li>Gupta, N., Li, W., Willard, B., Silverstein, R. L., McIntyre, T. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Proteasome+proteolysis+supports+stimulated+platelet+function+and+thrombosis%5BTitle%5D)+AND+%22Arterioscler+Thromb+Vasc+Biol%22%5BJournal%5D)">Proteasome proteolysis supports stimulated platelet function and thrombosis.</a> Arterioscler Thromb Vasc Biol. 34, 160-168 (2014).</li>
<li>Srikanthan, S., Li, W., Silverstein, R. L., McIntyre, T. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Exosome+poly-ubiquitin+inhibits+platelet+activation%2C+downregulates+CD36+and+inhibits+pro-atherothombotic+cellular+functions%5BTitle%5D)+AND+%22J+Thromb+Haemost%22%5BJournal%5D)">Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions.</a> J Thromb Haemost. 12, 1906-1917 (2014).</li>
<li>Li, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Thymidine+phosphorylase+participates+in+platelet+signaling+and+promotes+thrombosis%5BTitle%5D)+AND+%22Circ+Res%22%5BJournal%5D)">Thymidine phosphorylase participates in platelet signaling and promotes thrombosis.</a> Circ Res. 115, 997-1006 (2014).</li>
<li>Le Menn, R., Bara, L., Samama, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ultrastructure+of+a+model+of+thrombogenesis+induced+by+mechanical+injury%5BTitle%5D)+AND+%22J+Submicrosc+Cytol%22%5BJournal%5D)">Ultrastructure of a model of thrombogenesis induced by mechanical injury.</a> J Submicrosc Cytol. 13, 537-549 (1981).</li>
<li>Li, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((CD36+participates+in+a+signaling+pathway+that+regulates+ROS+formation+in+murine+VSMCs%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.</a> J Clin Invest. 120, 3996-4006 (2010).</li>
<li>Re-examining Acute Eligibility for Thrombolysis Task Force. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Review%2C+historical+context%2C+and+clarifications+of+the+NINDS+rt-PA+stroke+trials+exclusion+criteria%3A+Part+1%3A+rapidly+improving+stroke+symptoms%5BTitle%5D)+AND+%22Stroke%22%5BJournal%5D)">Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.</a> Stroke. 44, 2500-2505 (2013).</li>
<li>Mumaw, M. M., de la Fuente, M., Arachiche, A., Wahl, J. K. 3rd, Nieman, M. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Development+and+characterization+of+monoclonal+antibodies+against+Protease+Activated+Receptor+4+%28PAR4%29%5BTitle%5D)+AND+%22Thromb+Res%22%5BJournal%5D)">Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4).</a> Thromb Res. 135, 1165-1171 (2015).</li>
<li>Mumaw, M. M., de la Fuente, M., Noble, D. N., Nieman, M. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Targeting+the+anionic+region+of+human+protease-activated+receptor+4+inhibits+platelet+aggregation+and+thrombosis+without+interfering+with+hemostasis%5BTitle%5D)+AND+%22J+Thromb+Haemost%22%5BJournal%5D)">Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis.</a> J Thromb Haemost. 12, 1331-1341 (2014).</li>
<li>Modery-Pawlowski, C. L., Kuo, H. H., Baldwin, W. M., Sen Gupta, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+platelet-inspired+paradigm+for+nanomedicine+targeted+to+multiple+diseases%5BTitle%5D)+AND+%22Nanomedicine+%28Lond%29%22%5BJournal%5D)">A platelet-inspired paradigm for nanomedicine targeted to multiple diseases.</a> Nanomedicine (Lond). 8, 1709-1727 (2013).</li>
<li>Anselmo, A. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Platelet-like+nanoparticles%3A+mimicking+shape%2C+flexibility%2C+and+surface+biology+of+platelets+to+target+vascular+injuries%5BTitle%5D)+AND+%22ACS+Nano%22%5BJournal%5D)">Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries.</a> ACS Nano. 8, 11243-11253 (2014).</li>
<li>Modery, C. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Heteromultivalent+liposomal+nanoconstructs+for+enhanced+targeting+and+shear-stable+binding+to+active+platelets+for+site-selective+vascular+drug+delivery%5BTitle%5D)+AND+%22Biomaterials%22%5BJournal%5D)">Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery.</a> Biomaterials. 32, 9504-9514 (2011).</li>
<li>Woollard, K. J., Sturgeon, S., Chin-Dusting, J. P., Salem, H. H., Jackson, S. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Erythrocyte+hemolysis+and+hemoglobin+oxidation+promote+ferric+chloride-induced+vascular+injury%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.</a> J Biol Chem. 284, 13110-13118 (2009).</li>
<li>Ciciliano, J. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Resolving+the+multifaceted+mechanisms+of+the+ferric+chloride+thrombosis+model+using+an+interdisciplinary+microfluidic+approach%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach.</a> Blood. 126, 817-824 (2015).</li>
<li>Barr, J. D., Chauhan, A. K., Schaeffer, G. V., Hansen, J. K., Motto, D. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Red+blood+cells+mediate+the+onset+of+thrombosis+in+the+ferric+chloride+murine+model%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Red blood cells mediate the onset of thrombosis in the ferric chloride murine model.</a> Blood. 121, 3733-3741 (2013).</li>
<li>Dunne, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cadherin+6+has+a+functional+role+in+platelet+aggregation+and+thrombus+formation%5BTitle%5D)+AND+%22Arterioscler+Thromb+Vasc+Biol%22%5BJournal%5D)">Cadherin 6 has a functional role in platelet aggregation and thrombus formation.</a> Arterioscler Thromb Vasc Biol. 32, 1724-1731 (2012).</li>
<li>Lockyer, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((GPVI-deficient+mice+lack+collagen+responses+and+are+protected+against+experimentally+induced+pulmonary+thromboembolism%5BTitle%5D)+AND+%22Thromb+Res%22%5BJournal%5D)">GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism.</a> Thromb Res. 118, 371-380 (2006).</li>
<li>Zhou, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+C-terminal+CGHC+motif+of+protein+disulfide+isomerase+supports+thrombosis%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">The C-terminal CGHC motif of protein disulfide isomerase supports thrombosis.</a> J Clin Invest. , (2015).</li>
<li>Eckly, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanisms+underlying+FeCl3-induced+arterial+thrombosis%5BTitle%5D)+AND+%22J+Thromb+Haemost%22%5BJournal%5D)">Mechanisms underlying FeCl3-induced arterial thrombosis.</a> J Thromb Haemost. 9, 779-789 (2011).</li>
<li>Day, S. M., Reeve, J. L., Myers, D. D., Fay, W. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Murine+thrombosis+models%5BTitle%5D)+AND+%22Thromb+Haemost%22%5BJournal%5D)">Murine thrombosis models.</a> Thromb Haemost. 92, 486-494 (2004).</li>
<li>Cooley, B. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Murine+models+of+thrombosis%5BTitle%5D)+AND+%22Thromb+Res%22%5BJournal%5D)">Murine models of thrombosis.</a> Thromb Res. 129 Suppl 2, S62-S64 (2012).</li>
<li>Gupta, N., Li, W., McIntyre, T. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Deubiquitinases+Modulate+Platelet+Proteome+Ubiquitination%2C+Aggregation%2C+and+Thrombosis%5BTitle%5D)+AND+%22Arterioscler+Thromb+Vasc+Biol%22%5BJournal%5D)">Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis.</a> Arterioscler Thromb Vasc Biol. 35, 2657-2666 (2015).</li>
<li>Konstantinides, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Distinct+antithrombotic+consequences+of+platelet+glycoprotein+Ibalpha+and+VI+deficiency+in+a+mouse+model+of+arterial+thrombosis%5BTitle%5D)+AND+%22J+Thromb+Haemost%22%5BJournal%5D)">Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis.</a> J Thromb Haemost. 4, 2014-2021 (2006).</li>
<li>Versteeg, H. H., Heemskerk, J. W., Levi, M., Reitsma, P. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((New+fundamentals+in+hemostasis%5BTitle%5D)+AND+%22Physiol+Rev%22%5BJournal%5D)">New fundamentals in hemostasis.</a> Physiol Rev. 93, 327-358 (2013).</li>
<li>Yan, S. F., Mackman, N., Kisiel, W., Stern, D. M., Pinsky, D. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hypoxia%2FHypoxemia-Induced+activation+of+the+procoagulant+pathways+and+the+pathogenesis+of+ischemia-associated+thrombosis%5BTitle%5D)+AND+%22Arterioscler+Thromb+Vasc+Biol%22%5BJournal%5D)">Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis.</a> Arterioscler Thromb Vasc Biol. 19, 2029-2035 (1999).</li>
<li>Rahaman, S. O., Li, W., Silverstein, R. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vav+Guanine+nucleotide+exchange+factors+regulate+atherosclerotic+lesion+development+in+mice%5BTitle%5D)+AND+%22Arterioscler+Thromb+Vasc+Biol%22%5BJournal%5D)">Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.</a> Arterioscler Thromb Vasc Biol. 33, 2053-2057 (2013).</li>
<li>Silverstein, R. L., Li, W., Park, Y. M., Rahaman, S. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanisms+of+cell+signaling+by+the+scavenger+receptor+CD36%3A+implications+in+atherosclerosis+and+thrombosis%5BTitle%5D)+AND+%22Trans+Am+Clin+Climatol+Assoc%22%5BJournal%5D)">Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis.</a> Trans Am Clin Climatol Assoc. 121, 206-220 (2010).</li>
<li>Liu, J., Li, W., Chen, R., McIntyre, T. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Circulating+biologically+active+oxidized+phospholipids+show+on-going+and+increased+oxidative+stress+in+older+male+mice%5BTitle%5D)+AND+%22Redox+Biol%22%5BJournal%5D)">Circulating biologically active oxidized phospholipids show on-going and increased oxidative stress in older male mice.</a> Redox Biol. 1, 110-114 (2013).</li>
</ol>

The authors have nothing to disclose.

The FeCl3-induced model is one of the most widely used thrombosis models, which can not only provide valuable information about genetic modifications on platelet function and thrombosis7,8,16,19,31-33, but can also be a valuable tool for evaluation of therapeutic compounds and strategies for treatment and prevention of atherothrombotic diseases11,17,34-37. Here we have shown our modifications and refinements of this model and showed additional evidence of the utility of this technique, wh...

Arterial thrombosis (blood clot) is a common complication of many systemic diseases associated with chronic inflammation, including atherosclerosis, diabetes, obesity, cancer and chronic autoimmune rheumatologic disorders. Thrombi that occur in the arterial circulation stem from inappropriate platelet activation, aggregation and subsequent coagulatory mechanisms, and are implicated in heart attacks, strokes and extremity loss. The vessel wall is a complex system that includes multiple cell types and is influenced by a multitude of extrinsic factors including shear stress, circulating blood cells, hormones and cytokines, as well as expression of antioxidant proteins in the vessel wall. In vitro experiments cannot replicate this complex environment and therefore in vivo studies using animal models are critical to allow better understanding of mechanisms involved in thrombotic disorders.
Mice have been shown to have similar mechanisms to humans in terms of thrombosis, atherosclerosis, inflammation and diabetes1,2. Furthermore, transgenic and knockout mice can be created to test the function of specific gene products in a complex physiologic or pathologic environment. Such studies mimic human pathology and may provide important mechanistic information related to discovery of new pathways and therapies, as well as provide important details in characterizing drug effects on thrombosis.
Pathological arterial thrombi occur due to endothelial layer injury or dysfunction and exposure of the blood stream to the subendothelial matrix3,4. Various thrombosis models have been developed to induce this endothelial damage such as mechanical injury, photoreactive compound Rose Bengal-based oxidative injury and laser injury5. In this spectrum, Ferric chloride (FeCl3)-induced vascular injury is a widely used model of thrombosis. This reagent when applied to the outer aspect of vessels induces oxidative damage to vascular cells6-8, with loss of endothelial cell protection from circulating platelets and components of the coagulation cascade. The FeCl3 model is simple and sensitive to both anticoagulant and anti-platelets drugs, and has been performed on carotid and femoral arteries, jugular veins, and mesenteric and cremasteric arterioles and venules in mice, rats, guinea pigs and rabbits6-15.
One measurable parameter in this model is the elapsed time from injury to complete vessel occlusion, measured as blood flow cessation with a Doppler flow meter or under direct observation with intravital microscopy6,7,9. A range of times between 5 to 30 min has been reported in different studies in C57Bl6 mice7-10,16, suggesting that FeCl3 concentrations, types of anesthesia, surgical techniques, mouse age, genomic background, method of measuring blood flow, and other environmental variables have significant effects in this model. This wide variability makes it difficult to compare studies from different research groups and may make detection of subtle differences difficult.
With a vision to minimize such variabilities and establish a uniformly reproducible in vivo model system, we have refined the FeCl3-induced carotid artery model that makes the data highly reproducible with minimal variation6-10,16-19. In this paper we describe and share the skills and report several representative experimental examples that can benefit from this model.

<table><tbody><tr><td>Surgical Scissors - Tungsten Carbide</td><td>Fine Science Tools&amp;nbsp;</td><td>14502-14</td><td>cut and hold skin</td></tr><tr><td>Micro-Adson Forceps - Serrated/Straight/12 cm</td><td>Fine Science Tools&amp;nbsp;</td><td>11018-12</td><td>cut and hold skin</td></tr><tr><td>Metzenbaum Fino Scissors - Tungsten Carbide/Curved/Blunt-Blunt/14.5 cm</td><td>Fine Science Tools&amp;nbsp;</td><td>14519-14&amp;nbsp;&amp;nbsp;</td><td>to dissect and separate soft tissue</td></tr><tr><td>Ultra Fine Hemostat - Smooth/Curved/12.5 cm</td><td>Fine Science Tools&amp;nbsp;</td><td>13021-12</td><td>to dissect and separate soft tissue</td></tr><tr><td>Graefe Forceps - Serrated/Straight/10 cm</td><td>Fine Science Tools&amp;nbsp;</td><td>11050-10</td><td>to dissect and separate soft tissue</td></tr><tr><td>Dumont #5 Fine Forceps - Biology Tips/Straight/Inox/11 cm</td><td>Fine Science Tools&amp;nbsp;</td><td>11254-20&amp;nbsp;</td><td>Isolate vessel from surounding tissue</td></tr><tr><td>Dumont #5XL Forceps - Standard Tips/Straight/Inox/15 cm</td><td>Fine Science Tools&amp;nbsp;</td><td>11253-10</td><td>Isolate vessel from surounding tissue</td></tr><tr><td>Blunt Hook- 12 cm/0.3 mm Tip Diameter</td><td>Fine Science Tools&amp;nbsp;</td><td>10062-12</td><td>Isolate vessel from surounding tissue</td></tr><tr><td>Castroviejo Micro Needle Holders</td><td>Fine Science Tools&amp;nbsp;</td><td>12061-02</td><td>Needle holders</td></tr><tr><td>Suture Thread 4-0</td><td>Fine Science Tools&amp;nbsp;</td><td>18020-40</td><td>For fix the incisors to the plate</td></tr><tr><td>Suture Thread 6-0</td><td>Fine Science Tools&amp;nbsp;</td><td>18020-60</td><td>For all surgery and ligation</td></tr><tr><td>Kalt Suture Needles</td><td>Fine Science Tools&amp;nbsp;</td><td>12050-03</td><td></td></tr><tr><td>rhodamine 6G&amp;nbsp;</td><td>Sigma</td><td>83697-1G</td><td>To lebel platelets</td></tr><tr><td>FeCl&lt;sub&gt;3&lt;/sub&gt; (Anhydrous)</td><td>Sigma</td><td>12321</td><td>To induce vessel injury</td></tr><tr><td>Papaverine hydrochloride</td><td>Sigma</td><td>P3510</td><td>To inhibit gut peristalsis.</td></tr><tr><td>Medline Surgical Instrument Sterilization Steam Autoclave Tapes</td><td>Medline</td><td>111625</td><td>To fix the mouse to the plate</td></tr><tr><td>Fisherbrand&amp;trade;&amp;nbsp;Syringe Filters - Sterile 0.22 &amp;micro;m</td><td>Fisher</td><td>09-720-004</td><td>For sterlization of solutions injected to mice</td></tr><tr><td>Fisherbrand&amp;trade;&amp;nbsp;Syringe Filters - Sterile 0.45 &amp;micro;m</td><td>Fisher</td><td>09-719D</td><td>To filter the FeCl&lt;sub&gt;3&lt;/sub&gt; solution</td></tr><tr><td>Sterile Alcohol Prep Pad</td><td>Fisher</td><td>06-669-62</td><td>To sterilize the surgical site</td></tr><tr><td>Agarose&amp;nbsp;</td><td>BioExpress</td><td>E-3120-500</td><td>To make gel stage</td></tr><tr><td>Leica DMLFS fluorescent microscope</td><td>Leica</td><td></td><td>Intravital microscope</td></tr><tr><td>GIBRALTAR Platform and X-Y Stage System with heating plate attached.</td><td>npi electronic GmbH</td><td></td><td>http://www.npielectronic.de/products/micropositioners/burleigh/gibraltar.html</td></tr><tr><td>Streampix version 3.17.2 software</td><td>NorPix</td><td></td><td>https://www.norpix.com/</td></tr></tbody></table>

ferric chloride-induced murine thrombosis models

Ferric Chloride-induced Murine Thrombosis Models

Arterial thrombosis (blood clot) is a common complication of many systemic diseases associated with chronic inflammation, including atherosclerosis, diabetes, obesity, cancer and chronic autoimmune rheumatologic disorders. Thrombi are the cause of most heart attacks, strokes and extremity loss, making thrombosis an extremely important public health problem. Since these thrombi stem from inappropriate platelet activation and subsequent coagulation, targeting these systems therapeutically has important clinical significance for developing safer treatments. Due to the complexities of the hemostatic system, in vitro experiments cannot replicate the blood-to-vessel wall interactions; therefore, in vivo studies are critical to understand pathological mechanisms of thrombus formation. To this end, various thrombosis models have been developed in mice. Among them, ferric chloride (FeCl3) induced vascular injury is a widely used model of occlusive thrombosis that reports platelet activation and aggregation in the context of an aseptic closed vascular system. This model is based on redox-induced endothelial cell injury, which is simple and sensitive to both anticoagulant and anti-platelets drugs. The time required for the development of a thrombus that occludes blood flow gives a quantitative measure of vascular injury, platelet activation and aggregation that is relevant to thrombotic diseases. We have significantly refined this FeCl3-induced vascular thrombosis model, which makes the data highly reproducible with minimal variation. Here we describe the model and present representative data from several experimental set-ups that demonstrate the utility of this model in thrombosis research.

Carotid Artery Thrombosis Model 
In mice with C57BL6 background, we recommend using 7.5% FeCl3 to treat the vessel for 1 min as a starting point. Under treatment of 7.5% FeCl3, borders of the injured area and normal vessel wall are easily identified under microscope (See online video 1), suggesting that the endothelial layer was significantly damaged. The thrombi formed immediately upon FeCl3 treatment, and are observed...

We report a refined procedure of the ferric chloride (FeCl3)-induced thrombosis models on carotid and mesenteric artery as well as vein, characterized efficiently using intravital microscopy to monitor time to occlusive thrombi formation.

Arterial thrombosis (blood clot) is a common complication of many systemic diseases associated with chronic inflammation, including atherosclerosis, ...

The overall goal of this procedure is to produce ferric chloride-induced thrombosis in a mouse carotid artery model to obtain highly reproducible results as analyzed by intravital microscopy. These mice can help answer key questions about various disease or genetic disorders associated with platelet activation and the aggregation of closed vascular system. The main advantage of this technique are that it is simple and sensitive to both anticoagulant and antiplatelet drugs, and that it can be combined with other techniques.This method can be used to gain valuable insight into the pathophysiology of thrombosis, discover new mechanisms and therapies, and evaluate the effects of Novel drugs, including targeted nanomedicine on thrombosis. Visualization of this method is critical for learning the strategies for obtaining accurate blood flow cessation time. After confirming a lack of response to toe pinch, use small electric animal clippers to remove the fur from the neck and upper chest of an eight to 12-week-old mouse.Apply neutral petroleum eye ointment to animal's eyes, and tape the mouse in the supine position on the lid of a 15-centimeter tissue culture plate. Wrap a 4-0 suture around the incisors, and tape the ends of the suture to the lid to keep the neck straight. Then, move the animal under a surgical light source, and use an alcohol pad to sterilize the surgical site.Next, use Micro-Adson forceps to grasp the skin, and use surgical scissors to make a two to three-millimeter incision. Holding the incision with forceps, insert the scissors with the blades closed, and push the scissors subcutaneously toward the manubrium. Then, open the blades to free the skin from the subcutaneous layer.Now, make a midline incision from the manubrium to the hyoid bone, and use a fine hemostat and Graefe forceps to bluntly dissect the thin fascia between the submaxillary gland. When the trachea is visible, use the forceps to hold the soft tissue to the right of the manubrium, and insert the hemostat under the fascia toward the two o'clock position. Open the jaws of the hemostat to free the jugular vein from the surrounding tissue.Then, continue the incision through the fascia, soft tissue, and skin toward the two o'clock position until the right jugular vein is exposed. Now, attach a 30-gauge needle attached to a one-milliliter syringe containing 100 microliters of rhodamine 6G solution, and use a needle-holder to bend two to three millimeters of the tip 90 degrees. Then, holding the syringe with one hand and the soft tissue with the distal site of the jugular vein with the Graefe forceps in the other, insert the needle into the vessel.Stabilize the needle with the forceps, and inject the rhodamine. Once all of the platelet labeling solution has been administered, clamp the injection site with the forceps to prevent bleeding by opening the hemostat and inserting the instrument under the forceps to clamp the vessel wall of the injection site. Then, use a 6-0 suture to ligate the injection site.Bluntly dissect the soft tissue and fascia around the left submaxillary gland, and pull the gland toward the seven o'clock position to expose the left sternocleidomastoid muscle. Then, bluntly dissect the fascia between the left sternocleidomastoid muscle and the omohyoid and sternohyoid muscles to the left side of the trachea. When the fascia has been displaced, pass a needle with a 15-centimeter, 6-0 silk suture under the middle of the sternocleidomastoid muscle, and pull the two ends of the suture laterally toward the 10 o'clock position.Bluntly separate the thing sternohyoid and omohyoid muscles to expose the carotid artery. Then, use the hemostat to separate the soft tissue from the carotid artery without touching the artery. Using a fine-tipped forceps, lift the lateral fascia around the carotid artery while avoiding the vagus nerve and the artery.Then, use another fine-tipped forceps to puncture the fascia between the carotid artery and the vagus nerve. Now, pass a blunt hook through the hole to gently lift the carotid artery, and slide the fine-tipped forceps under the artery. Moving the hook and forceps in opposite directions along the artery, strip about five millimeters of advantigial soft tissue from the vessel from the surrounding tissue.Then, rinse a piece of U-shaped plastic with saline, and use the hook to gently lift the artery to allow for the placement of the plastic under the artery. The plastic will block the background fluorescence, preventing diffusing of the ferric chloride solution to the surrounding tissue, and they ensure that only the carotid artery is visible under the microscope. Immediately hydrate the carotid artery with two to three drops of saline.Then, transfer the mouse onto a fluorescent microsope stage under the 10X water lens, and fill the space between the lens and the artery with saline. Now, start the digital video recording software application, and obtain images of the normal vessel. If the vessel wall is integrated and uninjured, transfer the mouse to the Gibraltar platform, and use the corner of a paper towel to carefully blot the saline around the carotid artery in the surgical field without touching the artery.Then, use fine-tipped forceps to transfer a piece of ferric chloride-saturated filter paper directly on top of the carotid artery close to the distal end of the exposed artery. Make sure to place the filter paper close the distal end of the exposed carotid artery, which we will leave a short segment at the proximal side for observing the blood flow during the later phase of the injury. After one minute, remove the filter paper, and rinse the artery with at least two milliliters of saline.Return the mouse to the microscope stage, and obtain images of the vessel. The formation of the thrombus can be identified by the accumulation of the fluorescent platelets. Continue to image the vessel for 10 seconds every minute for the first 10 minutes, followed by 10 seconds every other minute until the end of the experiment.Tissue-type plasminogen activator profusion five minutes after ferric chloride injury demonstrates the initiation of thrombolysis about four minutes after the treatment. With the formed thrombi observed to undergo repeated size variations during the 30 minute observation period, but without a complete ablation of the platelet-mediated thrombus. Treatment with a polyclonal PAR4 antibody that delays PAR4 cleavage significantly prolongs the time to occlusive thrombus formation in the ferric chloride-induced carotid artery thrombosis model.Non-platelet red blood cell labeling experiments indicate that, while ferric chloride-induced thrombi are made up exclusively of vessel wall-adherent platelets, red blood cells do become trapped within the thrombus, contributing to the shape and occlusive property of the clot over time. Interestingly, while the initial thrombus is visualized within about 15 seconds of the injury to the mesenteric artery and vein, the formation of the thrombus within the mesenteric vessels is dramatically delayed to approximately 17 minutes in the mesenteric vein. And to nearly 24 minutes in the mesenteric artery, due at least in part to diffusion of the ferric chloride through the adipose tissue surrounding the mesenteric vessels.Once mastered, this refund ferric chloride injury induced thrombosis model can be finished in about a 30 to 60 minutes depending on the mastery used, if it is performed properly. While attempting this procedure, it is important to remember that the measure it will permit us is the elapsed attempt from the injury to the complete ways of occlusion, and a precise observation of the blood flow is critical for obtaining accurate results. This model may be combined with a transfusion of ex-vivo treated wild-type platelets to mimic platelet-specific knockouts for defining the function of regulatory pathways and platelets.This technique paved the way for researchers in the field of vascular biology to explore not only the role of platelets in thrombosis, but also under various other endothelium inflammatory conditions. After watching this video, you should have a good understanding of how to set up a ferric chloride-induced carotid artery thrombosis model in mice to achieve highly reproducible result using intravital microscope. Don't forget that ferric chloride can be extremely hazardous, and that precautions such as wearing the proper personal protective equipment should always be taken while performing this model.

ferric-chloride-induced-murine-thrombosis-models

Research

JoVE Journal

Medicine

The FeCl3 induced thrombosis model in mice is described herein. A method to monitor thrombus growth by intravital microscopy observation on a mesenteric vessel and by blood flow measurement in the carotid artery is presented.

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Here, we present the modifications necessary to a well characterized and commonly used small animal ferric chloride-induced (FeCl3) carotid artery injury model for use in a large animal vascular injury model. The resulting model can be utilized for pre-clinical trial assessment of both prophylactic and thrombolytic pharmacological and mechanical interventions.

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury

The present protocol describes how to use a FeCl3-mediated injury to induce arterial thrombosis, and how to collect and prepare arterial injury samples at various stages of thrombosis for electron microscopy analysis.

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

This study presents a protocol for establishing a reproducible, minimally invasive rat model of superior sagittal sinus thrombosis induced by ferric chloride, utilizing a silk-suture method in combination with laser speckle contrast imaging and high-resolution ultrasound for evaluation.

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis

The electrolytic induction of endothelial activation to the internal surface of the Inferior Vena Cava results in venous type thrombus formation due to endothelial activation and partial blood stasis, two components of Virchow's triad.

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

The mouse complete stasis model of inferior vena cava thrombosis yields quantifiable amounts of vein wall tissue and thrombus.  It has proven useful for evaluating interactions between the vein wall and the occlusive thrombus and in assessing the progression from acute to chronic inflammation.

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Fat content analysis is routinely conducted in studies utilizing murine obesity models.  Emerging methods in small animal CT imaging and analysis are providing for longitudinal detail rich fat content analysis.  Here we detail step by step procedures for performing small animal CT imaging, analysis, and visualization.

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

We describe procedures to quantify and characterize atherosclerotic lesions in mouse models using precision sectioning of the aortic sinus and ascending aorta combined with histochemical and immunohistochemical analysis.

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Preclinical models of intracerebral hemorrhage are utilized to mimic certain aspects of clinical disease. Thus, mechanisms of injury and potential therapeutic strategies may be explored. In this protocol, two models of intracerebral hemorrhage are described, intrastriatal (basal ganglia) injections of autologous blood or collagenase.

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Cancer is a complex disease that is influenced by the tissue surrounding the tumor as well as local pro- and anti-inflammatory mediators. Therefore, orthotropic injection models, rather than subcutaneous models may be useful to study cancer progression in a manner that better mimics human pathology.

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Learn ferric chloride-induced thrombosis in mouse carotid and mesenteric artery models using intravital microscopy. This sensitive technique enables real-time visualization of platelet aggregation and drug evaluation.

Ferric Chloride-induced Murine Thrombosis Models

Explore More Videos